| NCT06678659 | A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer | RECRUITING | PHASE1, PHASE2 | 2024-11-21 | 2028-10-30 | 2028-10-30 |
| NCT06536465 | The Clostridioides Difficile Trial of REC-3964 | TERMINATED | PHASE2 | 2024-10-14 | 2025-05-06 | 2025-05-06 |
| NCT06005974 | A Study of REC-4881 in Participants with Cancers Which Have an AXIN1 or APC Mutation | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-01-15 | 2027-01 | 2027-01 |
| NCT05552755 | Evaluate REC-4881 in Patients With FAP | RECRUITING | PHASE1, PHASE2 | 2023-07-10 | 2026-07 | 2026-07 |
| NCT05130866 | Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas | TERMINATED | PHASE2, PHASE3 | 2022-06-20 | 2025-08-18 | 2025-08-18 |
| NCT05085561 | The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 | COMPLETED | PHASE2 | 2022-03-17 | 2025-06-30 | 2025-06-30 |